CDNA

Caredx INC

-$70.6M

Net Activity

Institutions Holding

190

Popularity Rank

#3028

Avg Weight

0.27%

Total Value

$904.5M

Ownership Trend

190 institutions currently hold CDNA, with 94 net buyers and 91 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Neutral

Based on recent trading activity

Net Selling Institutions

91

Net Buying Institutions

94

Key Holders

View all 190 holding institutions

Quarterly Activity

Recent Activity

+$532.7M

Total Buy Value

$380.6M

Total Sell Value

New buy20
Trim59
Add74
Sold out32

94

Net Buyers

91

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

4

Filings (90d)

$2.47M

Total Est. Value

97K shares

Planned Shares

Last Filed 2026-06-29
FilerFiling DateEst. Value
Hanna John Walter JR2026-06-29$1.14M
Valantine Hannah2026-06-15$278K
Hanna John Walter JR2026-06-11$943K
Hanna John Walter JR2026-06-04$108K

Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

1

Filings (14d)

Data as of 2026-07-07
2026-07-07

CareDx (CDNA) completed the sale of its Swedish subsidiary and related lab products business to Eurobio on June 30, 2026, for $171.7 million in cash. On July 1, 2026, it also completed the acquisition of Naveris for $161.8 million in cash, with up to $100 million in additional milestone payments tied to revenue targets.

View Full Filing (SEC EDGAR)

View all Form 8-K filings

FAQ

Who are the top institutional investors holding CAREDX INC (CDNA)?
Major stakeholders currently include BlackRock, Inc. ($78.5M), Bamco INC /ny/ ($57.9M), State Street CORP ($47.9M). Based on the latest 13F filings, there are a total of 190 tracked investment funds and institutions maintaining positions in CDNA.
What is the overall institutional sentiment toward CDNA recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $70.6M, driven by 94 managers accumulating shares while 91 reduced their exposure.
Which institutions have been selling or reducing their CDNA positions?
In the latest period, 59 funds trimmed their holdings, and 32 managers completely exited their positions. The aggregate reported sell value was $380.6M.
Are there any notable investors adding CDNA to their portfolios?
Yes, buying activity remains notable. 20 institutions opened new positions in {ticker}, and 74 existing holders added to their shares. The total reported buy value for the quarter amounted to $532.7M.

Related Stocks